Authors : A.H. Abu , F.C. Iheukwumere , E.C. Ndubisi and U.N. Egu
Abstract: A total of 24 matured, parous, clinically sound West African dwarf goats aged 3-5 years were used to study the effect of human menopausal gonadotrophin (Pergonal®) and prostaglandin on leucocyte variations. The goats were divided into three groups of eight goats in each group identified as T1 (Control), T2 human menopausal gonadotrophin treated goats, T3 prostaglandin treated goats. The results show that total leucocyte count consistently increased from pre-treatment to 48 h post-oestrus in HMG-treated goats. There was no significant difference (p>0.05) in Dinoprost tromethiamine induced and natural oestrus. Neutrophil percentage was more during superovulatory oestrus followed by pre-treatment value. However, lymphocyte value was high during 48 h. Superovulatory oestrus, whereas in Dinoprost treated groups neutrophil was more during pre-treatment, but the difference was not significant (p>0.05) between treatment groups. The monocyte, eosinophil and basophil values were similar (p>0.05). The results of this study, indicate that HMG and prostaglandin treatments were not detrimental to the leucocyte count of goats.
A.H. Abu , F.C. Iheukwumere , E.C. Ndubisi and U.N. Egu , 2008. Leucocyte Variation During Human Menopausal Gonadotrophin (Pergonal®) and Prostaglandin Treatment in West African Dwarf Goats. Journal of Animal and Veterinary Advances, 7: 32-34.